Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials [0.03%]
反义寡核苷酸在脂质异常管理中的应用：临床试验述评
Ikponmwosa Jude Ogieuhi,Kristen Callender,God-Dowell O Odukudu et al.
Ikponmwosa Jude Ogieuhi et al.
Introduction: Elevated serum total cholesterol levels, very low-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, or a decreased serum high-density lipoprotein cholesterol concentration ...
Efficacy and Safety of Ultrasound Renal Denervation on Office Blood Pressure of Patients with Resistant Arterial Hypertension: A Systematic Review and Meta-analysis [0.03%]
超声肾去神经支配对难治性动脉高血压患者诊室血压疗效和安全性的系统评价和 meta 分析
Jose Guilherme Maia,Francinny Alves Kelly,Ocilio Ribeiro Gonçalves et al.
Jose Guilherme Maia et al.
Introduction: Resistant arterial hypertension (RAH) is one of the main causes of increased cardiovascular risk around the world. The benefits of ultrasound renal denervation (uRDN) as a non-invasive treatment are still no...
Psychometric Properties of the TWente Engagement with Ehealth Technologies Scale (TWEETS) Among Patients with Hypertension in Italy [0.03%]
意大利高血压患者使用蒂维特健康技术参与量表(TWEETS)的测验指标属性分析
Debora Rosa,Giulia Villa,Ilaria Marcomini et al.
Debora Rosa et al.
Introduction: Engagement with mobile health (mHealth) technologies among patients with hypertension is linked to reduced blood pressure and improved patient understanding of the condition. ...
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials [0.03%]
Nebivolol单药或联合治疗对高血压患者血压水平影响的系统评价和多水平荟萃分析
Athanasios Manolis,Paschalis Karakasis,Dimitrios Patoulias et al.
Athanasios Manolis et al.
Aims: To systematically appraise and summarize the available evidence from published randomized controlled trials considering the effect of nebivolol on blood pressure in patients with hypertension. ...
Hypertension in the Shadows of Conflict: The Impact of the Sudan War on Blood Pressure Management [0.03%]
冲突阴影下的高血压：苏丹战争对血压管理的影响
Ibrahim Nagmeldin Hassan,Nagmeldin Abuassa,Mohamed Ibrahim
Ibrahim Nagmeldin Hassan
The Sudan conflict has severely impacted hypertension management, exacerbating the condition through chronic stress, disrupted healthcare, and lifestyle changes. Hypertension, a major risk factor for cardiovascular diseases, worsens with wa...
Evaluation of the Human Placental Microbiota in Early- and Late-Onset Pre-Eclampsia [0.03%]
早发和晚发子痫前期胎盘微生物群的评估
Kehinde S Olaniyi,Irene Mackraj,Jagidesa Moodley et al.
Kehinde S Olaniyi et al.
Introduction: Despite many decades of research, the exact etiology of pre-eclampsia (PE) remains unknown. Several etiopathologies have been suggested, including the role of the placental microbiota. However, the existence...
Calling for Action: The Need of Large-Scale Cohorts to Uncover the Cardiovascular Risk in Non-Sleepy Obstructive Sleep Apnea [0.03%]
行动呼吁：亟需大规模队列研究以揭示不嗜睡型阻塞型睡眠呼吸暂停的心血管风险
Giuseppe Maiolino,Miguel Angel Martinez Garcia,Davide Soranna et al.
Giuseppe Maiolino et al.
Since randomized clinical trials currently do not support continuous positive airway pressure treatment of asymptomatic obstructive sleep apnea (OSA) we proposed the Obesity, Symptoms, and CARdiovascular assessment (OSCAR) algorithm to aid ...
Systematic Review and Meta-Analysis of Second-Generation Sham-Controlled Randomized Trials of Renal Denervation Therapy for Patients with Hypertension [0.03%]
sham对照的高血压患者肾去交感神经消融随机临床试验的系统评价和 meta分析
Clara Rocha Dantas,Artur De Oliveira Macena Lôbo,Artur Menegaz De Almeida et al.
Clara Rocha Dantas et al.
Introduction: Renal denervation has been associated with substantial and sustained blood pressure reduction and is considered to serve as an alternative treatment for patients with resistant hypertension. However, the fir...
Prolonged Time-to-antihypertensive Therapy Worsens Organ Damage and Blood Pressure Control in Arterial Hypertension [0.03%]
高血压患者长期未接受降压治疗会加重靶器官损害并恶化血压控制效果
Maria Lembo,Maria Virginia Manzi,Daniela Pacella et al.
Maria Lembo et al.
Introduction: Delay in arterial hypertension (AH) diagnosis and late therapy initiation may affect progression towards hypertensive-mediated organ damage (HMOD) and blood pressure (BP) control. ...
PCSK9 Inhibitors: Is the Time Ripe for the "Fast Track" Use Independently on the LDL-C Baseline Values in Acute Coronary Syndrome? [0.03%]
急性冠脉综合征患者使用PCSK9抑制剂时是否可超越LDL胆固醇基线值而快速启用？
Alessandro Bellis,Ciro Mauro,Emanuele Barbato et al.
Alessandro Bellis et al.
The low-density lipoprotein cholesterol (LDL-C) lowering decreases the risk to develop major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS). Therefore, the "fast track" use of PCSK9 inhibitors (PCSK9i) h...